PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.21%
Revenue growth at 50-75% of 9843.T's 7.63%. Martin Whitman would worry about competitiveness or product relevance.
8.31%
Gross profit growth similar to 9843.T's 9.17%. Walter Schloss would assume both firms track common industry trends.
25.60%
Positive EBIT growth while 9843.T is negative. John Neff might see a substantial edge in operational management.
27.07%
Operating income growth above 1.5x 9843.T's 3.01%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
40.70%
Positive net income growth while 9843.T is negative. John Neff might see a big relative performance advantage.
40.71%
Positive EPS growth while 9843.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
40.71%
Positive diluted EPS growth while 9843.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.58%
10Y revenue/share CAGR at 50-75% of 9843.T's 100.82%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-16.43%
Negative 5Y CAGR while 9843.T stands at 55.78%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
39.52%
3Y revenue/share CAGR similar to 9843.T's 37.74%. Walter Schloss would assume both companies experience comparable short-term cycles.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
146.54%
Similar net income/share CAGR to 9843.T's 160.39%. Walter Schloss would see parallel tailwinds or expansions for both firms.
26.35%
5Y net income/share CAGR at 50-75% of 9843.T's 48.34%. Martin Whitman might see a shortfall in operational efficiency or brand power.
62.87%
3Y net income/share CAGR above 1.5x 9843.T's 33.32%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
172.32%
10Y equity/share CAGR at 50-75% of 9843.T's 234.58%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
21.13%
Below 50% of 9843.T's 106.37%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
67.38%
3Y equity/share CAGR above 1.5x 9843.T's 40.12%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-25.00%
Cut dividends over 10 years while 9843.T stands at 276.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
50.00%
Below 50% of 9843.T's 108.89%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
38.46%
3Y dividend/share CAGR at 50-75% of 9843.T's 62.07%. Martin Whitman might see a weaker short-term approach to distributing cash.
23035.00%
Our AR growth while 9843.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.52%
Inventory growth well above 9843.T's 13.46%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.02%
Asset growth above 1.5x 9843.T's 3.62%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.55%
BV/share growth above 1.5x 9843.T's 1.90%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
1.97%
We have some new debt while 9843.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-46.41%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.